1. Home
  2. INDP vs YQ Comparison

INDP vs YQ Comparison

Compare INDP & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • YQ
  • Stock Information
  • Founded
  • INDP 2000
  • YQ 2012
  • Country
  • INDP United States
  • YQ China
  • Employees
  • INDP N/A
  • YQ N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • YQ Other Consumer Services
  • Sector
  • INDP Health Care
  • YQ Real Estate
  • Exchange
  • INDP Nasdaq
  • YQ Nasdaq
  • Market Cap
  • INDP 6.0M
  • YQ 19.4M
  • IPO Year
  • INDP N/A
  • YQ 2020
  • Fundamental
  • Price
  • INDP $12.00
  • YQ $2.23
  • Analyst Decision
  • INDP Strong Buy
  • YQ
  • Analyst Count
  • INDP 2
  • YQ 0
  • Target Price
  • INDP $238.00
  • YQ N/A
  • AVG Volume (30 Days)
  • INDP 699.0K
  • YQ 58.7K
  • Earning Date
  • INDP 08-11-2025
  • YQ 09-03-2025
  • Dividend Yield
  • INDP N/A
  • YQ N/A
  • EPS Growth
  • INDP N/A
  • YQ N/A
  • EPS
  • INDP N/A
  • YQ N/A
  • Revenue
  • INDP N/A
  • YQ $25,546,613.00
  • Revenue This Year
  • INDP N/A
  • YQ N/A
  • Revenue Next Year
  • INDP N/A
  • YQ N/A
  • P/E Ratio
  • INDP N/A
  • YQ N/A
  • Revenue Growth
  • INDP N/A
  • YQ N/A
  • 52 Week Low
  • INDP $7.56
  • YQ $1.26
  • 52 Week High
  • INDP $66.64
  • YQ $3.19
  • Technical
  • Relative Strength Index (RSI)
  • INDP 53.68
  • YQ 57.45
  • Support Level
  • INDP $9.45
  • YQ $2.15
  • Resistance Level
  • INDP $13.40
  • YQ $2.39
  • Average True Range (ATR)
  • INDP 2.17
  • YQ 0.16
  • MACD
  • INDP 0.20
  • YQ 0.00
  • Stochastic Oscillator
  • INDP 29.39
  • YQ 54.29

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About YQ 17 Education & Technology Group Inc.

17 Education & Technology Group Inc is an education technology company in China. It offers smart, in-school, teaching and learning SaaS offerings assist students, teachers, schoolmasters and educational authorities across China. It also offer other educational products and services that complement students' in-school learning. Geographically group operates in China.

Share on Social Networks: